| 23199-3 |
Leptospira sp Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Leptospira sp IgG Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23199-3 |
|
IA |
|
|
Both |
|
|
|
0 |
Leptospira IgG Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Leptospirosis; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; SUDS |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 232-9 |
Erythromycin |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Erythromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
232-9 |
|
MLC |
|
|
Observation |
|
|
|
0 |
Erythromycin Islt MLC |
|
|
|
Y |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; c212; EES; Erygel; Erythromycn; ID; Ilosone; Ilotycin; Iltycin; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 2320-0 |
Gamma glutamyl cysteine synthetase |
CCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
U/mL RBC |
|
|
|
|
|
|
CHEM |
|
2320-0 |
|
|
|
|
Both |
|
|
|
0 |
GGCS RBC-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; Cys; Erythrocytes; Gamma glutamylcysteine synthetase; GGCS; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.44 |
1 |
|
|
|
|
|
|
|
U/mL{RBCs} |
|
|
|
0 |
| 23200-9 |
Leptospira sp Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Leptospira sp IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23200-9 |
|
|
|
|
Both |
|
|
|
0 |
Leptospira IgG Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Leptospirosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23201-7 |
Leptospira sp Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Leptospira sp IgM Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23201-7 |
|
IA |
|
|
Both |
|
|
|
0 |
Leptospira IgM Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Leptospirosis; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; SUDS |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23202-5 |
Leptospira sp Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Leptospira sp IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23202-5 |
|
|
|
|
Both |
|
|
|
0 |
Leptospira IgM Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Leptospirosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23203-3 |
Leptospira sp Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Leptospira sp Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23203-3 |
|
IF |
|
|
Both |
|
|
|
0 |
Leptospira Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Leptospirosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23204-1 |
Leptospira sp Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Leptospira sp Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23204-1 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Leptospira Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Leptospirosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; St; Stains; Stn; Tissue; Tissue, unspecified |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23205-8 |
Leptospira sp DNA |
PrThr |
Body fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Leptospira sp DNA [Presence] in Body fluid by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23205-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Leptospira DNA Fld Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Leptospirosis; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.63 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23206-6 |
Leptospira sp DNA |
PrThr |
Tiss |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Leptospira sp DNA [Presence] in Tissue by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23206-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Leptospira DNA Tiss Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Leptospirosis; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification |
2.63 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23207-4 |
Leptospira sp subtype |
Prid |
XXX |
Pt |
Nom |
|
|
ACTIVE |
Leptospira subtype [Identifier] in Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23207-4 |
|
|
|
|
Both |
|
|
|
0 |
Leptospira Subtyp Spec |
|
|
|
|
|
ID; Identity or presence; Infectious Disease; InfectiousDisease; Leptospira Subtyp; Leptospirosis; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; species; spp; To be specified in another part of the message; Unspecified |
2.69 |
1.0n |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 23208-2 |
Leptospira borgpetersenii serovar Tarrasovi Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23208-2 |
|
|
|
|
Both |
|
|
|
0 |
L borgp Tarra Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; L borgp; L borgp Tarra; L borgpetersenii; Leptospirosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23209-0 |
Leptospira borgpetersenii serovar Tarrasovi Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl |
|
ACTIVE |
Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23209-0 |
|
Aggl |
|
|
Both |
|
|
|
0 |
L borgp Tarra Ab Ser Ql Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; L borgp; L borgp Tarra; L borgpetersenii; Leptospirosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 2321-8 |
Gamma glutamyl cysteine synthetase |
CCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2321-8 |
|
|
|
|
Both |
|
|
|
0 |
GGCS Ser-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; Cys; Gamma glutamylcysteine synthetase; GGCS; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
| 23210-8 |
Listeria sp Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Listeria sp Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23210-8 |
|
|
|
|
Both |
|
|
|
0 |
Listeria Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Listeriosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23211-6 |
Listeria sp Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl |
|
ACTIVE |
Listeria sp Ab [Presence] in Serum by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23211-6 |
|
Aggl |
|
|
Both |
|
|
|
0 |
Listeria Ab Ser Ql Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Listeriosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23212-4 |
Lumpy skin disease virus |
PrThr |
Tiss |
Pt |
Ord |
Microscopy.electron |
|
ACTIVE |
Lumpy skin disease virus [Presence] in Tissue by Electron microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23212-4 |
|
Microscopy.electron |
|
|
Both |
|
|
|
0 |
LSDV Tiss Ql EM |
|
|
|
|
|
Capripoxvirus; Dis; Diseases; Dz; EM; ID; Infectious Disease; InfectiousDisease; Integument; Knopvelsiekte; LSDV; Lumpy skin disease; Micro; Microbiology; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; Vet; Veterinary |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23213-2 |
Lumpy skin disease virus Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Lumpy skin disease virus Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
23213-2 |
|
IF |
|
|
Both |
|
|
|
0 |
LSDV Ab Titr Ser IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Capripoxvirus; Dilution factor; Dilution Factor (Titer); Dis; Diseases; Dz; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Integument; Knopvelsiekte; LSDV; Lumpy skin disease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Vet; Veterinary |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 23214-0 |
Lumpy skin disease virus Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Lumpy skin disease virus Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23214-0 |
|
IB |
|
|
Both |
|
|
|
0 |
LSDV Ab Ser Ql IB |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Capripoxvirus; Dis; Diseases; Dz; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Integument; Knopvelsiekte; LSDV; Lumpy skin disease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; Vet; Veterinary; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23215-7 |
Lumpy skin disease virus Ab.Neut |
PrThr |
Ser |
Pt |
Ord |
Neut |
|
ACTIVE |
Lumpy skin disease virus neutralizing antibody [Presence] in Serum by Neutralization test |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23215-7 |
|
Neut |
|
|
Both |
|
|
|
0 |
LSDV NAb Ser Ql Nt |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Capripoxvirus; Conventional virus neutralization test; cVNT; Dis; Diseases; Dz; ID; Infectious Disease; InfectiousDisease; Integument; Knopvelsiekte; LSDV; Lumpy skin disease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Serum virus neutralization; SR; SVN; Vet; Veterinary; Virus neutralization test; VNT |
2.72 |
1.0n |
|
|
|
|
|
|
|
|
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23216-5 |
Lumpy skin disease virus Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Lumpy skin disease virus Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23216-5 |
|
|
|
|
Both |
|
|
|
0 |
LSDV Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Capripoxvirus; Dis; Diseases; Dz; ID; Infectious Disease; InfectiousDisease; Integument; Knopvelsiekte; LSDV; Lumpy skin disease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23217-3 |
Lumpy skin disease virus Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Lumpy skin disease virus Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
23217-3 |
|
|
|
|
Both |
|
|
|
0 |
LSDV Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Capripoxvirus; Dilution factor; Dilution Factor (Titer); Dis; Diseases; Dz; ID; Infectious Disease; InfectiousDisease; Integument; Knopvelsiekte; LSDV; Lumpy skin disease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 23218-1 |
Lumpy skin disease virus Ag |
PrThr |
Tiss |
Pt |
Ord |
IA |
|
ACTIVE |
Lumpy skin disease virus Ag [Presence] in Tissue by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23218-1 |
|
IA |
|
|
Both |
|
|
|
0 |
LSDV Ag Tiss Ql IA |
|
|
|
|
|
Antigen; Antigens; Capripoxvirus; Dis; Diseases; Dz; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Integument; Knopvelsiekte; LSDV; Lumpy skin disease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; Tissue; Tissue, unspecified; Vet; Veterinary |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 23219-9 |
Lumpy skin disease virus Ag |
PrThr |
XXX |
Pt |
Ord |
IA |
|
ACTIVE |
Lumpy skin disease virus Ag [Presence] in Specimen by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
23219-9 |
|
IA |
|
|
Both |
|
|
|
0 |
LSDV Ag Spec Ql IA |
|
|
|
|
|
Antigen; Antigens; Capripoxvirus; Dis; Diseases; Dz; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Integument; Knopvelsiekte; LSDV; Lumpy skin disease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified; Vet; Veterinary |
2.69 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 2322-6 |
Gamma glutamyl transferase |
CCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Gamma glutamyl transferase [Enzymatic activity/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2322-6 |
|
|
|
|
Both |
|
|
|
0 |
GGT Amn-cCnc |
|
|
|
Y |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Catalytic Concentration; Chemistry; Gamma glutamyl transpeptidase; Gamma-GTP; GGT; GGTP; GT; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.68 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
